Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Donate
English En EnglishEn FrançaisFr
  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us
  • Home
  • »
  • Resources
  • »
  • The time to invest is now: fighting malaria in the Sahel

Share this page

Resources

Videos


Date:
02/08/2017

The time to invest is now: fighting malaria in the Sahel

For the 25 million children who live across the Sahel, where there is a seasonal surge in malaria incidence, the World Health Organization recommends seasonal malaria chemoprevention (SMC) as an effective tool in the fight against malaria. 

For less than $5 one child is protected with SMC each year. To support our continued efforts as a GiveWell Top Charity protecting all 25 million children in the Sahel from malaria visit http://www.givewell.org/charities/malaria-consortium.

Many children will still miss out on receiving SMC in due to lack of funding and production capacity for quality assured medicines used in SMC (SP+AQ). With children in sub-Saharan Africa 14 times more likely to die before the age of five than those living elsewhere in the world, it is time to do more. Malaria can be prevented- in the Sahel, SMC can play a crucial role.

Country: The Gambia | Guinea | Chad | Burkina Faso | Nigeria | Niger | Mali

Keywords: Advocacy and policy | Malaria |

 

Related content

11 January 2017

Seasonal malaria chemoprevention: Transforming the malaria landscape in the Sahel

Type: Learning brief
6 February 2017

ACCESS-SMC Impact: Three years of SMC in the Sahel

Type: Infographic
4 May 2016

Seasonal Malaria Chemoprevention: Relieving the burden of malaria in the Sahel

Type: Project
4 May 2016

Protecting those most at risk of malaria in the Sahel

Type: Project
4 May 2016

Bringing Seasonal Malaria Chemoprevention to the Sahel

Type: Project
31 July 2017

Reaching all children, no matter what

Type: Case study

 

« Back to Videos

Sign up for our newsletters here:

  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us
© 2021 Malaria Consortium | Charity No. 1099776 | Company No. 4785712 | Privacy notice | Modern Slavery Statement